Quotient provides comprehensive bioanalytical services within a state-of-the-art facility. The experienced team of globally recognized experts can quickly develop, validate and implement bioanalytical LC-MS, GC-MS and ICP-MS assays for small and large molecule drugs, biomarkers and elements in compliance with regulatory expectations. Our team have extensive project experience to support all stages of drug development from early preclinical, first in man (FIM) and through to Phase II and III studies.
We produce bioanalytical LC-MS, GC-MS and ICP-MS assays in compliance with regulatory standards. Three of our eight triple quadrupole instruments are new, ultra-high sensitivity Waters XEVO TQ-XS systems equipped with UPLC. In addition to this, we have a Sciex 6600 triple ToF that allows collection of high-resolution MS data and can be used to quantify an impressive range of molecules from small molecules to proteins. When used in conjunction with the wide range of extraction technologies available to us we can develop highly selective and sensitive assays.